Your Messages Inbox
Your Article Summary
See Latest ArticlesCommitted to quality and safety ?EUR Cognis starts voluntary REACH registration of its pharmaceutical excipie
Corporate News Releases - The Healthcare Sales & Marketing Network, 10/06/08
The European Union's REACH chemical legislation also affects the pharmaceutical industry, as it covers all substances for synthesis or processing used in the manufacture of pharmaceuticals. To offer its customers the best possible service, Cognis is submitting its complete range of pharmaceutical excipients and products for inclusion in the pre-registration process. This step ensures that Cognis Nutrition & Health will be able to offer an uninterrupted supply of these products.
| Previous Article | Next Article |
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardinal Health Foundation names finalists in public service announcement contest for prescription drug abuse
Cardinal Health, 07/02/09
PhRMA Statement on Health Care Reform
PhRMA, 06/15/09
Managing the Crisis of Marginalization
PharmExec, 06/09/09
Article Search
Sponsor